Author:
Zhang Qihong,Ren Wei,Dushkin Alexandr V.,Su Weike
Reference35 articles.
1. In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist;Koike;J. Hypertens. Suppl.: Off. J. Int. Soc. Hypertens.,2001
2. Novel amides and esters prodrugs of olmesartan: synthesis, bioconversion, and pharmacokinetic evaluation;Park;Bioorg. Med. Chem. Lett,2010
3. Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension;Ruilope;Vasc. Health Risk Manag.,2008
4. Efficacy and tolerability of olmesartan medoxomil/olmesartan medoxomil plus hydrochlorothiazide in stage 1 and stage 2 hypertension;Bakshi;J. Adv. Res. Biol. Sci.,2012
5. Preparation and characterization of self-microemulsifying drug delivery system of olmesartan medoxomil for bioavailability improvement;Prajapati;J. Pharm.,2013
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献